True North Enterprises

Study: Northwell’s anti-pathogen UV tech is A-OK

By GREGORY ZELLER // A New York City startup backed by Northwell Health’s new business-development division may be on the verge of eliminating infectious pathogens from hospitals. An ultraviolet disinfection technology deployed by biotech startup PurpleSun – officially, the “focused multivactor ultraviolet device” – dramatically lowers the risk of hospital-acquired infections by eliminating 97.7 percent of pathogens in operating rooms, according to a new study published in the American Journal of Infection Control. The study…